Corrigendum to "Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent" [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023)

Renuka T.R. Menon; Tali Feferman; Revital Aricha; Miriam C. Souroujon; Sara Fuchs

doi:10.1016/j.jneuroim.2009.07.001

Corrigendum to "Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent" [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023)

Renuka T.R. Menon, Tali Feferman, Revital Aricha, Miriam C. Souroujon, Sara Fuchs

Life Sciences

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	129
Number of pages	1
Journal	Journal of Neuroimmunology
Volume	215
Issue number	1-2
DOIs	https://doi.org/10.1016/j.jneuroim.2009.07.001
State	Published - 30 Oct 2009

Bibliographical note

Funding Information:
This research was supported by grants from The Muscular Dystrophy Association of America (MDA), The Association Francaise Cortre les Myopathies (AFM), The European Commission (EC, No QLG1-CT-2001-10918, QLRT-2001-00225 and LSHN-CT-2006-037833) and The Chief Scientist Office, Israel Ministry of Health.

Access to Document

10.1016/j.jneuroim.2009.07.001

Cite this

Menon, R. T. R., Feferman, T., Aricha, R., Souroujon, M. C., & Fuchs, S. (2009). Corrigendum to "Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent" [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023). Journal of Neuroimmunology, 215(1-2), 129. https://doi.org/10.1016/j.jneuroim.2009.07.001

@article{1389ccb6e78248c5a633c9a3762c5fb6,

title = "Corrigendum to {"}Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent{"} [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023)",

author = "Menon, {Renuka T.R.} and Tali Feferman and Revital Aricha and Souroujon, {Miriam C.} and Sara Fuchs",

note = "Funding Information: This research was supported by grants from The Muscular Dystrophy Association of America (MDA), The Association Francaise Cortre les Myopathies (AFM), The European Commission (EC, No QLG1-CT-2001-10918, QLRT-2001-00225 and LSHN-CT-2006-037833) and The Chief Scientist Office, Israel Ministry of Health.",

year = "2009",

month = oct,

day = "30",

doi = "10.1016/j.jneuroim.2009.07.001",

language = "אנגלית",

volume = "215",

pages = "129",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier",

number = "1-2",

}

Menon, RTR, Feferman, T, Aricha, R, Souroujon, MC & Fuchs, S 2009, 'Corrigendum to "Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent" [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023)', Journal of Neuroimmunology, vol. 215, no. 1-2, pp. 129. https://doi.org/10.1016/j.jneuroim.2009.07.001

Corrigendum to "Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent" [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023). / Menon, Renuka T.R.; Feferman, Tali; Aricha, Revital et al.
In: Journal of Neuroimmunology, Vol. 215, No. 1-2, 30.10.2009, p. 129.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to "Suppression of experimental autoimmune myasthenia gravis by combination therapy

T2 - Pentoxifylline as a steroid-sparing agent" [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023)

AU - Menon, Renuka T.R.

AU - Feferman, Tali

AU - Aricha, Revital

AU - Souroujon, Miriam C.

AU - Fuchs, Sara

N1 - Funding Information: This research was supported by grants from The Muscular Dystrophy Association of America (MDA), The Association Francaise Cortre les Myopathies (AFM), The European Commission (EC, No QLG1-CT-2001-10918, QLRT-2001-00225 and LSHN-CT-2006-037833) and The Chief Scientist Office, Israel Ministry of Health.

PY - 2009/10/30

Y1 - 2009/10/30

UR - http://www.scopus.com/inward/record.url?scp=70349740876&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2009.07.001

DO - 10.1016/j.jneuroim.2009.07.001

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:70349740876

SN - 0165-5728

VL - 215

SP - 129

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

IS - 1-2

ER -

Corrigendum to "Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent" [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023)

Bibliographical note

Access to Document

Other files and links

Cite this